Bay City Capital Fund V LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bay City Capital Fund V LP
CIK #0001401826
EDGAR Form CIK 2011 - 2026
3 [0001401826]
4 [0001401826]
Form 3/4/5 Subject 2011 - 2026
Bay City Capital Fund V Co-Investment Fund LP
Enliven Therapeutics Inc
Bay City Capital Fund V LP
Bay City Capital Management V LLC
Bay City Capital LLC
Goldfischer Carl
Interleukin Genetics Inc
Epizyme Inc
Sunesis Pharmaceuticals Inc
Dermira Inc
Hyperion Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Enliven Therapeutics Inc IMRA
Stock Option (right to buy) · derivative
2020-03-16 Grant 15,457 $0.00
Enliven Therapeutics Inc IMRA
Common Stock
2020-03-16 Conversion 690,232
Enliven Therapeutics Inc IMRA
Common Stock
2020-03-16 Conversion 13,148
Enliven Therapeutics Inc IMRA
Stock Option (right to buy) · derivative
2020-03-16 Grant 15,457 $0.00
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
2020-03-16 Conversion 16,103
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
2020-03-16 Conversion 845,008
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
2020-03-16 Conversion 61,378
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
2020-03-16 Conversion 3,220,915
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
2020-03-16 Conversion 5,372
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
2020-03-16 Conversion 281,878
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
2020-03-16 Conversion 16,103
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
2020-03-16 Conversion 3,220,915
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
2020-03-16 Conversion 5,372
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
2020-03-16 Conversion 281,878
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
2020-03-16 Conversion 845,008
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
2020-03-16 Conversion 61,378
Enliven Therapeutics Inc IMRA
Common Stock
2020-03-16 Conversion 690,232
Enliven Therapeutics Inc IMRA
Common Stock
2020-03-16 Conversion 13,148
Interleukin Genetics Inc ILIU
Common Stock
2016-07-29 Buy 29,616,700 $0.10 2,961,670
Interleukin Genetics Inc ILIU
Common Stock
2016-07-29 Buy 564,386 $0.10 56,439
showing 20 of 137 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com